Metabolic and Cardiovascular Drug Development
With an array of cardiovascular and metabolic disease models, surgical procedures, preclinical cardiac risk assessment services, tailored specialty toxicology services, and much more, we anticipate challenges and are an expert partner to move your studies to their next phase.
Charles River provides animal models specific for metabolic and cardiovascular research studies. If your research requires the use of specialized or genetically modified models, our experts can work with you to customize and create them for your study using the latest model creation technologies. Through our preconditioning services, we offer an array of cardiovascular surgical procedures and custom diets so that you receive your animal study ready.
Cardiovascular and Metabolic Research Products and Services
- Cardiovascular disease models
- Metabolic disease models
- C57BL/6 DIO mice for metabolic research
- Surgically altered cardiovascular models
- Custom diets
- Animal model creation
- Animal health surveillance
Guidebooks
- Laboratory Mouse and Rat Colony Management
- Rodent Model Genetic Quality Control
- Modern Strategies for Infection Surveillance of Rodent Populations
Research Models and Services Catalog
As a leading provider of research animal models, we offer a broad portfolio of study-ready and genetically engineered models and related support services.
Download the Catalog
Metabolic and cardiovascular drug discovery remains a critical area of focus within the scientific community. Whether targeting cardiovascular diseases (like coronary artery disease or hypertension) or metabolic diseases (like obesity), Charles River helps accelerate your discoveries through innovative target identification and validation, complex in vitro and in vivo pharmacology models, and a strong chemistry and disease biology foundation, all of which assist in translating basic research to clinical reality.
Metabolic and Cardiovascular Drug Discovery Services
Charles River’s integrated in vitro and in vivo cardiovascular and metabolic experts provide a comprehensive approach and the expert interpretations needed to understand the pathophysiological foundation of cardiovascular and metabolic disorders and facilitate translational efforts to help you find new cardiovascular and metabolic therapies and advance your program. From individual specialty toxicology and IND enabling studies to tailored packages and total laboratory support, our deeply experienced team can design and execute programs that anticipate challenges and aid a smooth transition to the clinic.
Safety Assessment Services
We offer full-service support across the entire drug discovery and development continuum to complement and enhance metabolic and cardiovascular drug development programs, including: